User profiles for Michael Lock

Michael Lock

Professor, University of Western Ontario
Verified email at lhsc.on.ca
Cited by 7691

Stereotactic ablative radiotherapy versus standard of care palliative treatment in patients with oligometastatic cancers (SABR-COMET): a randomised, phase 2, open …

…, S Gaede, AV Louie, C Haasbeek, L Mulroy, M Lock… - The Lancet, 2019 - thelancet.com
Background The oligometastatic paradigm suggests that some patients with a limited number
of metastases might be cured if all lesions are eradicated. Evidence from randomised …

[HTML][HTML] Stereotactic ablative radiotherapy for the comprehensive treatment of oligometastatic cancers: long-term results of the SABR-COMET phase II randomized trial

…, AV Louie, C Haasbeek, L Mulroy, M Lock… - Journal of Clinical …, 2020 - ncbi.nlm.nih.gov
PURPOSE The oligometastatic paradigm hypothesizes that patients with a limited number of
metastases may achieve long-term disease control, or even cure, if all sites of disease can …

External beam accelerated partial breast irradiation versus whole breast irradiation after breast conserving surgery in women with ductal carcinoma in situ and node …

…, S Mukherjee, S Gudelis, D D'Souza, M Lock… - The Lancet, 2019 - thelancet.com
Background Whole breast irradiation delivered once per day over 3–5 weeks after breast
conserving surgery reduces local recurrence with good cosmetic results. Accelerated partial …

Prediction of radiation pneumonitis by dose–volume histogram parameters in lung cancer—a systematic review

G Rodrigues, M Lock, D D'Souza, E Yu… - Radiotherapy and …, 2004 - Elsevier
BACKGROUND AND PURPOSE: To perform a systematic review of the predictive ability of
various dose–volume histogram (DVH) parameters (V dose , mean lung dose (MLD), and …

Effect of standard vs dose-escalated radiation therapy for patients with intermediate-risk prostate cancer: the NRG oncology RTOG 0126 randomized clinical trial

…, G Morton, D Hamstra, M Seider, MI Lock… - JAMA …, 2018 - jamanetwork.com
Importance Optimizing radiation therapy techniques for localized prostate cancer can affect
patient outcomes. Dose escalation improves biochemical control, but no prior trials were …

Fenfluramine hydrochloride for the treatment of seizures in Dravet syndrome: a randomised, double-blind, placebo-controlled trial

…, BS Galer, A Gammaitoni, A Mistry, G Morrison, M Lock… - The Lancet, 2019 - thelancet.com
Background Dravet syndrome is a rare, treatment-resistant developmental epileptic
encephalopathy characterised by multiple types of frequent, disabling seizures. Fenfluramine has …

[BOOK][B] The Jonglei Canal: impact and opportunity

P Howell, M Lock, S Cobb - 1988 - books.google.com
The vast area of swamp and wetlands of the Southern Sudan, the Sudd, absorbs and dissipates
by evaporation about half the inflow from the upper catchment of the White Nile. Ways …

Fenfluramine for treatment-resistant seizures in patients with Dravet syndrome receiving stiripentol-inclusive regimens: a randomized clinical trial

…, G Farfel, BS Galer, G Morrison, M Lock… - JAMA …, 2020 - jamanetwork.com
Importance Fenfluramine treatment may reduce monthly convulsive seizure frequency in
patients with Dravet syndrome who have poor seizure control with their current stiripentol-…

Single-dose Live Oral Cholera Vaccine CVD 103-HgR Protects Against Human Experimental Infection With Vibrio cholerae O1 El Tor

…, M Gurwith, RH Hall, RA Kessler, M Lock… - Clinical Infectious …, 2016 - academic.oup.com
Background. No licensed cholera vaccine is presently available in the United States.
Cholera vaccines available in other countries require 2 spaced doses. A single-dose cholera …

Radiotherapy for liver metastases: a review of evidence

M Høyer, A Swaminath, S Bydder, M Lock… - International Journal of …, 2012 - Elsevier
Over the past decade, there has been an increasing use of radiotherapy (RT) for the treatment
of liver metastases. Most often, ablative doses are delivered to focal liver metastases with …